NEWSROOM

PHBI

PHBI – Pharmagreen Announces Affirmed MOU To Acquire Licensed California Cannabis Company

Jan 6, 2022

  CARSON CITY, NV, Jan. 06, 2022 -- McapMediaWire -- Pharmagreen Biotech, Inc., (OTCQB: PHBI), today announced an affirmed  memorandum  of understanding  (MOU)  to  acquire  Long  Valley Farms LLC, a California based cannabis company. The acquisition includes land, infrastructure, and a Cannabis cultivation license for the operation of a cannabis business in the State of California. This acquisition is a strategic component of Pharmagreen’s strategy to convert the revenue potential of its...

read more

PHBI – Pharmagreen Biotech Announces Up-Listing To OTCQB Venture Market

Dec 20, 2021

  CARSON CITY, NV, Dec. 20, 2021 -- McapMediaWire -- Pharmagreen Biotech Inc., (OTCQB: PHBI), a specialized tissue cultured starter plantlet production company, targeting the CBD Hemp and Cannabis Industries, today announced its application to the OTCQB Venture Market has been approved and the company is today quoted on the OTCQB. Operated by The OTC Markets, the OTCQB is the premier marketplace for entrepreneurial and development stage U.S. and international companies that are committed...

read more

PHBI – Pharmagreen Previews Imminent Next Strategic Steps Advancing Its Proprietary Cannabis Tissue Culture Technology Into Recurring Revenue Generation

Dec 16, 2021

    CARSON CITY, NV, Dec. 16, 2021 -- McapMediaWire -- Pharmagreen Biotech, Inc., (OTC PINK: PHBI), today continued in the release of a series of management updates from CEO Peter Wojcik as the company begins to convert the revenue potential of its proprietary cannabis tissue culture technology into realized revenue. The update is included in its entirety below: CEO Peter Wojcik Strategic Update Today, I am pleased to share two imminent next steps that will be major milestones for...

read more

PHBI – Pharmagreen Plans To Transition Cannabis Industry Economics Making Adoption Of Its Proprietary Plant Tissue Technology An Industry Standard

Dec 9, 2021

  CARSON CITY, NV, Dec. 09, 2021 -- McapMediaWire -- Pharmagreen Biotech, Inc., (OTC PINK: PHBI), today released a second management update form CEO Peter Wojcik.  Today’s update provides further information on the company’s strategy to convert the revenue potential of its proprietary intellectual property into realized revenue.  The first update can be reviewed and the following link: Pharmagreen Taps Revenue Potential of Proprietary Cannabis Tissue Culture Technology Asset  Today’s...

read more

PHBI – Pharmagreen Taps Revenue Potential of Proprietary Cannabis Tissue Culture Technology Asset

Dec 2, 2021

  Carson City, Nevada, Dec. 02, 2021 -- McapMediaWire -- Pharmagreen Biotech, Inc., (OTC Pink: PHBI), today released a management update from CEO Peter Wojcik. The update is the first in a series of narratives breaking out the company's strategy as it begins to convert the revenue potential of its proprietary intellectual property into realized revenue. The update is included in its entirety below: CEO Peter Wojcik Strategic Update Pharmagreen has reached an exciting transition stage...

read more

Categories

Mcap MediaWire - Costumer Service

Translate »